Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.223EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.640.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.11 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.355EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.34.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.71 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.33.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.465EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
S.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.215EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.82EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.462EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.218EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.550EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.261EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.238EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used